Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Travere Therapeutics
TVTX
$5.68B
| $12.5M | ﹤0.01% |
856,699
+432,500
| +102% | +$6.51M |
|
1577
HUTCHMED
HCM
$2.17B
| $12.5M | ﹤0.01% |
698,378
-898,968
| -56% | -$21.7M |
|
|
CSLT
1578
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $12.4M | ﹤0.01% |
17,102,219
+450,000
| +3% | +$501K |
|
|
AVTR.PRA
1579
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $12.3M | ﹤0.01% |
274,950
-208,800
| -43% | -$11.8M |
|
1580
Azenta
AZTA
$1.54B
| $12.3M | ﹤0.01% |
404,317
-802,757
| -67% | -$29.2M |
|
|
RPT
1581
Rithm Property Trust
RPT
$98.2M
| $12.3M | ﹤0.01% |
322,704
-9,136
| -3% | -$695K |
|
1582
Equity Bancshares
EQBK
$1.06B
| $12.3M | ﹤0.01% |
712,530
-159,010
| -18% | -$4M |
|
|
CMBT
1583
CMB.TECH NV
CMBT
$4.73B
| $12.2M | ﹤0.01% |
1,076,247
-105,166
| -9% | -$1.08M |
|
1584
Hewlett Packard
HPE
$72B
| $12.2M | ﹤0.01% |
1,256,816
-384,943
| -23% | -$5.04M |
|
|
SHLX
1585
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $12.2M | ﹤0.01% |
1,221,228
+1,221,227
| +122,122,700% | +$20.8M |
|
1586
SPDR Gold Trust
GLD
$143B
| $12.1M | ﹤0.01% |
81,686
-10,732
| -12% | -$1.6M |
|
|
EVLO
1587
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $12.1M | ﹤0.01% |
161,043
-1,078
| -0.7% | -$103K |
|
|
TECX
1588
Tectonic Therapeutic
TECX
$623M
| $12.1M | ﹤0.01% |
64,721
+46,457
| +254% | +$10.9M |
|
|
SWT
1589
DELISTED
Stanley Black & Decker, Inc.
SWT
| $12.1M | ﹤0.01% |
171,900
+71,900
| +72% | +$6.84M |
|
1590
AeroVironment
AVAV
$9.92B
| $12.1M | ﹤0.01% |
197,719
+197,302
| +47,315% | +$12.3M |
|
1591
iShares Russell 3000 ETF
IWV
$20.4B
| $12M | ﹤0.01% |
80,722
-33,196
| -29% | -$5.91M |
|
1592
Liberty Latin America Class C
LILAK
$1.66B
| $12M | ﹤0.01% |
1,362,602
+407,699
| +43% | +$5.49M |
|
1593
Liberty Energy
LBRT
$3.51B
| $11.9M | ﹤0.01% |
4,409,480
+21,900
| +0.5% | +$153K |
|
|
MOMO
1594
Hello Group
MOMO
$861M
| $11.8M | ﹤0.01% |
544,655
-124,695
| -19% | -$3.72M |
|
1595
American Airlines Group
AAL
$10.1B
| $11.7M | ﹤0.01% |
962,080
-11,547,541
| -92% | -$263M |
|
1596
Minerva Neurosciences
NERV
$206M
| $11.7M | ﹤0.01% |
243,364
-10,000
| -4% | -$603K |
|
1597
Hyster-Yale Materials Handling
HY
$619M
| $11.7M | ﹤0.01% |
291,544
+8,339
| +3% | +$420K |
|
1598
Live Nation Entertainment
LYV
$42.7B
| $11.7M | ﹤0.01% |
257,055
-304,849
| -54% | -$18.8M |
|
1599
Hess Midstream
HESM
$5.2B
| $11.6M | ﹤0.01% |
1,142,783
-698,484
| -38% | -$13.1M |
|
1600
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $11.6M | ﹤0.01% |
149,396
+23,172
| +18% | +$2.05M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.